<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000800439">
  <TermName>tumor-infiltrating lymphocyte therapy</TermName>
  <TermPronunciation>(TOO-mer-IN-fil-TRAY-ting LIM-foh-site THAYR-uh-pee)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A type of treatment in which tumor-infiltrating lymphocytes (a type of immune cell that can recognize and kill cancer cells) are removed from a patient’s tumor and grown in large numbers in a laboratory. These lymphocytes are then given back to the patient by infusion to help the immune system kill the cancer cells. Also called TIL therapy.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000801156" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tumor-infiltrating lymphocyte therapy&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000801157" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;terapia con linfocitos infiltrantes tumorales&quot;" language="es" id="_4"/>
  <SpanishTermName>terapia con linfocitos infiltrantes tumorales</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Tipo de tratamiento para el que se usan linfocitos infiltrantes tumorales (tipo de célula inmunitaria que reconoce y destruye células cancerosas) que se extraen del tumor del paciente para producirlos en grandes cantidades en el laboratorio.  Luego, estos linfocitos se devuelven al paciente en una infusión para ayudar al sistema inmunitario a destruir células cancerosas. También se llama terapia LIT.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2020-01-22</DateFirstPublished>
  <RelatedInformation>
    <RelatedExternalRef UseWith="en" xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy">T-cell Transfer Therapy</RelatedExternalRef>
  </RelatedInformation>
</GlossaryTerm>
